CXCL8 and cancer: The diverse effectors and downstream targets involved in IL-8 signaling promote ECs’ angiogenic responses, increase the proliferation and survival of both ECs and cancer cell, and enhance the migration efficiency of cancer cells, ECs, and TANs infiltrating tumor sites [154] (Fig. 2).